Patent protected L-glutamine therapy, in addition to the Fast Track designation from the FDA, has received orphan drug status in the US and Europe. The double-blind, prospective, randomized,
Nafcillin had hit nearly $62m sales for 12 months ending September 2012 in US, according to IMS. The injection comes with the company’s PreventIV Measures packaging and labeling
The new five-year project, which aims to optimize binding kinetics for drug candidates to improve drug design, will receive €20m in funding from Europe’s Innovative Medicines Initiative, a
The collaboration will help Hovione’s expertise and experience to overcome drug delivery challenges and the supply of GMP materials from phase I to commercial scale using Solvias state
The new shots help consumers suffering from occasional sleeplessness to fall asleep fast for longer duration, thereby allowing refreshed wakeup with no grogginess. Celestial Seasonings vice president and
The study, which enrolled patients undergoing cataract surgery in a two-arm trial, will evaluate the efficacy and safety of BromSite against the DuraSite drug delivery technology. InSite Vision
As a result of shifting market preferences for integrated drug discovery activities, the company will close its Bothell site, US, and transit the site’s biology capabilities and certain
SteriPack has also implemented QAD at its facilities in Ireland, Poland and Malaysia. SteriPack USA president Tony Paolino said QAD Enterprise Applications offer SteriPack USA business process continuity
As part of the collaboration, DNA2.0 and Newcastle plan to use their synergies in computational design and the development of industrially relevant bacterial strains. DNA2.0 will also use
When administered intravenously, KRN5500 acts immediately and provides prolonged pain mitigation. DARA CEO David Drutz said KRN5500 demonstrated statistical and clinical superiority over placebo in a small Phase
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.